The study of antagonist regimen and progesterone-stimulated ovarian stimulation regimen in preimplantation genetic testing

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055371

Enrollment

Unknown

Registered

2022-01-08

Start date

2022-01-03

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

younger- PPOS group:No

younger-GnRH-antagonist group:No

elder-PPOS group:No

elder-GnRH-antagonist group:No

Eligibility

Sex/Gender

Female

Age

25 Years to 45 Years

Inclusion criteria

Inclusion criteria: Preimplantation genetic diagnosis cycles.

Exclusion criteria

Exclusion criteria: In vitro fertilization cycles, ICSI cycles for non-PGT purpose.

Design outcomes

Primary

Measure	Time frame
euploid blastocyst formation rate;	—

Secondary

Measure	Time frame
oocyte maturation rate;	—

Countries

China

Contacts

Public ContactGong Yan

Sichuan Women and Children's Hospital

gongyan_496181657@qq.com+86 15208393996

Outcome results